Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
76 Cards in this Set
- Front
- Back
- 3rd side (hint)
Which drug has anabolic effects in muscle and catabolic effects in lipid cells to shift balance of body mass to muscle mass and reduce central adiposity?
|
Growth hormone
(Somatotropin) |
|
|
Primary effects of GH (somatotropin) are mediated by what?
|
Insulin-like growth factor 1 (IGF-1) and IGF-2
|
|
|
Adverse effects of GH
|
intracranial HTN, scoliosis, hypothyroidism, pancreatitis, gynecomastia, peripheral edema, mylagias, arthragias, carpal tunnel syndrome
|
|
|
Clinical uses of GH
(4) |
1) Peds pts with short stature
2) GH deficiency in adults 3) Wasting in AIDS pts 4) Short bowel syndrome (improves GI function) |
|
|
What are uses for Dopamine agonists?
(Bromocriptine, Cabergoline, Pergolide) |
1) suppress prolactin release
2) Parkinson's - reduce levodopa requirements 3) Tx of hyperprolactinemia and acromegaly |
|
|
SE of dopamine agonists
|
Nausea
Headache Light headedness orthostatic hypotension fatigue psychiatric manifestations |
|
|
How much more potent is T3 than T4?
|
3-4 times
|
|
|
What happens to T4 and T3 in hyperthyroidism?
|
Production T4/T3 increased;
half-lives decreased |
|
|
What happens to T4 and T3 in hypothyroidism?
|
Production T4/T3 decreased;
Half-lives increased |
|
|
What are the S/S of toxicity of thyroxine in both childrena and adults?
|
Children: restlessness, insomnia, accelerated bone maturation and growth
Adults: Increased nervousness, heat intolerance, episodes of palpitation and tachycardia, unexplained wt. loss. |
|
|
What do you do if you see S/S of toxicity with thyroxine?
|
Monitor TSH
|
|
|
What does chronic overtreatment of thyroxine increase the risk of?
|
A fib
accelerated osteoporosis |
|
|
What drugs can induce hypothyroidism?
|
Iodides
Lithium Fluoride Thioamides ASA Amiodarone Perchlorate Ethionamide Thiocynate Cytokines (interferons/Interleukins) Bexarotene |
|
|
Which are short-medium acting corticosteroids?
|
hydrocortisone
cortisone prednisone methylprednisolone |
|
|
Which are medium acting corticosteroids?
|
Triamcinolone
|
|
|
Which are the long acting corticosteroids?
|
Betamethasone
Dexamethasone |
|
|
Which are the mineralcorticoids?
|
Fludrocortisone
|
|
|
TRUE/FALSE
There are the same potency ratios of glucocorticoids to mineralcorticoids? |
False
|
|
|
What developments do you monitor for with adrenocortical agents?
|
Hyperglycemia
Glycosuria Na retention with edema or HTN Hypokalemia Peptic ulcer Osteoporosis Hidden infections |
|
|
When would you use great caution when prescribing adrenocortical agents?
|
Peptic ulcer
heart disease HTN with HF infection psychosis DM osteoporosis glaucoma |
|
|
What are the properties of mineralcorticoids?
|
Promotes reabsorption of Na from distal convoluted tubule, cortical collecting renal tubules, and coupled to K and hydrogen ion excretion
|
|
|
Where is aldosterone synthesized?
|
zona glomerulosa of the adrenal cortex
ACTH produces moderate stimulation of release of aldosterone, but in the abscence of ACTH 50% is produced (by RAAS or other factors) |
|
|
What is a steroid hormone produced by adrenal gland, which is a precursor of aldosterone? It's secretion is under control of ACTH.
|
Deoxycorticosterone
|
|
|
Which drug is a synthetic steroid used for treatment of adrenal insufficiency and orthostatic hypotension?
|
Fludrocortisone (florinef)
|
|
|
Name 3 rapidly acting insulin preparations
|
Lispro
Aspart Glulisine |
|
|
Name 3 benefits of rapid-acting insulins
Lispro Aspart Glulisine |
1) more closely mimics normal endogenous prandial insulin secretion (than regular)
2) can use immediately before meals 3) perfered insulin for pumps |
|
|
What are the onset, peak and duration of rapid-acting insulins?
Lispro Aspart Glulisine |
Onset: 5-15 min
Peak: 1-2 hrs Duration: 3-5 hrs |
|
|
Name the 3 short acting insulins
|
Regular Novolin R
Regular Hunulin R Regular Exubra |
|
|
Which insulin is taken 30-45 minutes before meals to avoid mismatch?
|
Regular Novolin R and Humulin R
|
|
|
What drug is inhaled (1-4mg) powder premeal; determined by body weight?
|
Exubera
|
|
|
What is the conversion from mg to units for exubera?
|
1mg=3units regular insulin
3mg=8units regular insulin |
|
|
What other med besides exubera is given to type 1 diabetics?
|
longer acting insulin
|
|
|
Can type 2 diabetics use exubera as monotherapy?
|
Si
(or with oral agents or with longer acting insulin) |
|
|
What are the pharmacokinetics of short-acting insulins?
|
onset: within 30 min
peak: 2-3 hrs duration: 4-12 hrs |
Regular Novolin R
Regular Hunulin R Regular Exubra |
|
What has absorption and onset which are delayed by combining appropriate amounts of insulin and protamine?
|
Intermediate-acting insulins
NPH Humulin N NPH Novolin N (they are mixed with rapid or short-acting insulins) |
Intermediate-acting insulins
|
|
What are premixed insulins made of?
|
Rapid or short-acting mixed with NPH
|
|
|
What does Novolin 70/30 or Humulin 70/30 mean?
|
70% NPH
30% regular insulin |
what % NPH/Regular
|
|
What does 75/25 NPL, lispro mean?
|
75% Neutral protamine lispro/
25% insulin lispro |
|
|
What does 70/30 NPA, Aspart mean?
|
70% Neutral protamine aspart/
30% insulin aspart |
|
|
TRUE/FALSE
Insulin glargine and detemir are given separately. |
TRUE
|
|
|
What kind of insulins are detemir (Levemir) and glargine (Lantus)?
|
long-acting insulins
|
|
|
How does insulin detemir (Levemir) work?
|
Availablility is prolonged by increasing self-aggregaion in SQ tissue and reversible albumin binding.
(less hypoglycemia than NPH) [given 2 x a day] |
|
|
How does insulin glargine (Lantus) work?
|
Insulin molecules slowly dissolve away from the crystalline depot and provide slow, continuous level of circulating insulin.
[given once daily, 2 times if necessary] |
|
|
What are the pharmacokinetics of long-acting insulins?
|
Onset: 1-3 hrs
Peak: none, max effect 4-6 hrs Duration: 24+ hrs |
Levemir
Lantus |
|
What are the S/S of hypoglycemia?
|
Tachycardia, palpitations, sweating, tremulousness, nausea, hunger, convulsions, coma
|
|
|
What are the causes of hypoglycemia?
|
Meal delay, inadequate carbo intake, unusual physical exertion, larger dose than immediate need
|
|
|
What is the treatment for hypoglycemia?
|
1) Oral glucose tabs, sugar containing beverage or food.
2) 20-50 mL D50 IV over 2-3 min 3) Glucagon 1 mg SQ or IM |
|
|
Name 3 second generation oral diabetic agents
|
Glyburide
Glipizide Glimepiride |
|
|
Which oral diabetic agent is contraindicated in hepatic and renal impairment?
|
Glyburide (diabeta, micronase, glynase)
|
|
|
Which oral diabetic agent makes you hypoglycemic and flush if you drink ETOH with it?
|
Glyburide (diabeta, micronase, glynase)
|
|
|
What is the dose of Glyburide (diabeta, micronase, glynase)?
|
2.5-10 mg QD in am
|
|
|
What is the dose of Glipizide (Glucotrol, Glucotrol XL)?
|
5-15 mg 30 min prior to breakfast
Max 40mg, divide doses XL provides 24hr action |
|
|
Which oral diabetic agent causes less hypoglycemia per lecture?
|
Glipizide (Glucotrol, Glucotrol XL)
shorter half-life |
|
|
Which oral diabetic agent is 90% metabolized in liver and 10% in urine, and is contraindicated in hepatic impairment?
|
Glipizide (Glucotrol, Glucotrol XL)
|
|
|
Which oral diabetic agent is completely metabolized by the liver, has the lowest dose and the longest 1/2 life?
|
Glimepiride (Amaryl)
dose=1-8mg QD |
|
|
What is a caution to administration of oral diabetic agents?
|
Elderly and CV disease
|
|
|
What are meglitinides?
|
Oral diabetic agents that modulate beta-cell insulin release by regulating K efflux through K channels. They have 2 common binding sites to sulfonylureas and 1 unique binding site.
|
|
|
What is the dose of Repaglinide (prandin) and cautions?
|
0.25-4mg 15-30 min before meals
caution with renal or hepatic disfunction - CYP3A4 |
|
|
What are the adverse effects of Repaglinide (Prandin)?
|
Hypoglycemia - if meal skipped/delayed
|
|
|
Which oral diabetic agent has no sulfur structure?
|
Repaglinide (Prandin)
|
|
|
What is Sitagliptin (januvia)?
|
-Inhibitor of DPP4
-enzyme that degrades incretin and other GLP1 like molecules -increases insulin release and decreases hepatic glucose production |
|
|
What is the dose for Sitagliptin (januvia)?
|
100mg PO QD, with diet and exercise
|
|
|
Does Sitagliptin (januvia) require a renal adjustment?
|
YES
|
|
|
Can Sitagliptin (januvia) be used for Type I diabetics?
|
nope, only for type 2
monotherapy or combo with other oral agents |
|
|
What drug can be used for severe hypoglycemia, endocrine diagnosis, beta-blocker poisioning, or radiology of the bowel?
|
Glucagon
|
|
|
What are the pharmacologic effects of glucagon?
|
1) producton of cAMP, facilitating catabolism of stored glycogen and increased gluconeogeneis and ketogenesis.
2) potent inotropic and chronotropic effect on heart 3) large doses cause relaxation of the intestine |
|
|
What is a peptide produced in the parathyroid gland that has rapid clearance in liver and kidney and regulates Ca and Phos flux across the membranes in bone and kidney?
|
Parathyroid hormone (PTH)
|
|
|
What is a steroid produced in the skin and found in food; hydroxylated in the liver and further converted in the kidney; cleared in the liver - determined by binding affinity?
|
Vitamin D
|
|
|
What is the net effect on serum levels of PTH?
|
Increased serum Ca
Decreased serum Phos |
|
|
What is the net effect on serum levels of Vitamin D?
|
Increased serum Ca
Increased serum Phos |
|
|
What are the major causes of hypocalcemia?
|
Hypoparathyroidism, Vitamin D deficiency, kidney disease, and malabsorption.
|
|
|
What are the major causes of hypercalcemia?
|
Hyperparathyroidism, cancer, thiazide therapy
|
|
|
What are the major causes of hyperphosphatemia?
|
renal failure, hypoparathyroidism, vit D intoxication, tumoral calcinosis
|
|
|
What is the clinical presentation of hyperphospatemia?
|
due to the effects of hypocalcemia
(neuromuscular - tetany, muscle cramps, etc) |
|
|
What are the major causes of hypophosphatemia?
|
Primary hyperparathyroidism, vit D deficiency, idiopathic hypercalciuria, vit D resistant rickets, other renal phos. wasting, overuse of binders, TPN without proper Phos.
|
|
|
What is the clinical presentation of hypophospatemia?
|
Muscle weakness, rhabdo, osteomalacia
|
|